Representative Gilbert Ray Cisneros, Jr. (D-California) recently sold shares of Humana Inc. (NYSE:HUM). In a filing disclosed on June 06th, the Representative disclosed that they had sold between $1,001 and $15,000 in Humana stock on May 30th. The trade occurred in the Representative's "150 MAIN STREET TRUST > BANK OF AMERICA" account.
Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):
- Sold $15,001 - $50,000 in shares of SpringWorks Therapeutics NASDAQ: SWTX on 7/1/2025.
- Purchased $1,001 - $15,000 in shares of AppLovin NASDAQ: APP on 7/1/2025.
- Sold $1,001 - $15,000 in shares of Amdocs NASDAQ: DOX on 6/30/2025.
- Purchased $1,001 - $15,000 in shares of CoStar Group NASDAQ: CSGP on 6/30/2025.
- Purchased $15,001 - $50,000 in shares of CoStar Group NASDAQ: CSGP on 6/27/2025.
- Purchased $1,001 - $15,000 in shares of Xiaomi OTCMKTS: XIACF on 6/27/2025.
- Sold $1,001 - $15,000 in shares of ASML NASDAQ: ASML on 6/27/2025.
- Sold $1,001 - $15,000 in shares of Willis Towers Watson Public NASDAQ: WTW on 6/26/2025.
- Sold $1,001 - $15,000 in shares of Boston Scientific NYSE: BSX on 6/26/2025.
- Sold $1,001 - $15,000 in shares of Liberty Media Corporation - Liberty Formula One Series C NASDAQ: FWONK on 6/26/2025.
Humana Stock Up 3.8%
HUM stock traded up $8.46 during mid-day trading on Tuesday, reaching $231.89. The company had a trading volume of 1,621,693 shares, compared to its average volume of 1,825,412. The firm has a fifty day simple moving average of $234.87 and a 200 day simple moving average of $257.29. The company has a debt-to-equity ratio of 0.71, a quick ratio of 1.91 and a current ratio of 1.91. The company has a market capitalization of $27.99 billion, a price-to-earnings ratio of 16.40, a price-to-earnings-growth ratio of 1.51 and a beta of 0.44. Humana Inc. has a fifty-two week low of $206.87 and a fifty-two week high of $406.09.
Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings data on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $10.07 by $1.51. The firm had revenue of $32.11 billion during the quarter, compared to analysts' expectations of $32 billion. Humana had a return on equity of 14.47% and a net margin of 1.42%. Humana's revenue was up 8.4% on a year-over-year basis. During the same period in the previous year, the firm posted $7.23 earnings per share. Analysts forecast that Humana Inc. will post 16.47 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
HUM has been the topic of several analyst reports. Oppenheimer increased their target price on shares of Humana from $300.00 to $310.00 and gave the stock an "outperform" rating in a research report on Thursday, May 1st. Raymond James Financial upgraded shares of Humana from a "market perform" rating to an "outperform" rating and set a $315.00 target price for the company in a research note on Thursday, May 1st. Mizuho boosted their price objective on shares of Humana from $305.00 to $316.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 9th. Robert W. Baird lifted their target price on shares of Humana from $270.00 to $300.00 and gave the stock a "neutral" rating in a report on Tuesday, April 15th. Finally, Bank of America lowered their target price on shares of Humana from $320.00 to $260.00 and set a "neutral" rating for the company in a report on Tuesday, June 17th. Sixteen analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $282.57.
View Our Latest Stock Analysis on HUM
Institutional Investors Weigh In On Humana
Hedge funds have recently modified their holdings of the stock. Pinnacle Wealth Management Advisory Group LLC increased its position in Humana by 3.6% in the 4th quarter. Pinnacle Wealth Management Advisory Group LLC now owns 1,070 shares of the insurance provider's stock worth $272,000 after purchasing an additional 37 shares during the last quarter. Mather Group LLC. boosted its position in Humana by 21.0% in the 4th quarter. Mather Group LLC. now owns 236 shares of the insurance provider's stock valued at $60,000 after buying an additional 41 shares during the last quarter. Capital Advisors Ltd. LLC boosted its position in shares of Humana by 26.1% in the 4th quarter. Capital Advisors Ltd. LLC now owns 208 shares of the insurance provider's stock worth $53,000 after purchasing an additional 43 shares during the last quarter. Retirement Planning Co of New England Inc. boosted its position in shares of Humana by 4.7% in the 4th quarter. Retirement Planning Co of New England Inc. now owns 966 shares of the insurance provider's stock worth $245,000 after purchasing an additional 43 shares during the last quarter. Finally, LFA Lugano Financial Advisors SA lifted its holdings in Humana by 56.3% during the fourth quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider's stock worth $32,000 after acquiring an additional 45 shares in the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.
About Representative Cisneros
Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California's 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.
Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California's 31st Congressional District. He declared candidacy for the 2026 election.
Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor's degree in political science from George Washington University in 1994, a master's in business administration from Regis University in 2002, and a master's degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.
About Humana
(
Get Free Report)
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Featured Articles
Before you consider Humana, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Humana wasn't on the list.
While Humana currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.